CLINICAL_TRIALS
trial_result
· 2008-09-23
Clinical Trial Update: Rosuvastatin and Ischemia Reperfusion [Phase 2]
Summary
A Phase 2 trial evaluating rosuvastatin for ischemia and ischemia-reperfusion injury has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Radboud University Medical Center | Conditions: Ischemia | Phase 2 | Status: COMPLETED